Essentially, the clinic administering the peptide (which the patients paid for out-of-pocket) later phoned patients to ask if they felt better, and wrote up the responses
This work was supported by the National Natural Science Foundation of China (32371255 and 32071203 to LHZ, 32130022 and 82121005 to HEX, 82404881 to QNY)
Saxenda is a GLP-1 receptor agonist administered as a daily subcutaneous injection for weight management in adults with BMI 30 kg/m or 27 kg/m with comorbidities Lumps commonly result from localised inflammation, lipohypertrophy from repeated injections in the same area, or rarely from infection or improper technique Prevention requires rotating injection sites within the abdomen, thigh, or upper arm, maintaining at least 1 cm distance between consecutive injections Proper technique includes using a new needle each time, injecting at 90 degrees, and keeping the needle in skin for at least 6 seconds after injection Most lumps resolve spontaneously with site avoidance
healthcare facilities follow this method under the CDCs multi-dose vial protocol
Today it is peptides that have taken over